Carafate is not a proton pump inhibitor (PPI). It belongs to a completely different drug class called antiulcer agents, and it works through a physical mechanism rather than a chemical one. While PPIs reduce the amount of acid your stomach produces, Carafate forms a protective barrier over damaged tissue to shield it from acid, digestive enzymes, and bile salts.
How Carafate Works
Carafate’s active ingredient, sucralfate, acts locally in your digestive tract rather than being absorbed into your bloodstream. When it reaches an ulcer or damaged area, it binds to the exposed tissue and creates a paste-like coating. This physical barrier blocks stomach acid, pepsin (a digestive enzyme), and bile salts from making contact with the wound. Think of it like a bandage for the inside of your stomach or upper intestine.
The drug also reduces pepsin activity in gastric juice by about 32% and has a small amount of acid-neutralizing capacity, roughly 14 to 16 milliequivalents per dose. But its primary job is protection, not acid reduction. It also stimulates the production of a natural compound that helps maintain the mucous lining of your digestive tract.
How PPIs Work Differently
PPIs take an entirely different approach. They target the acid-producing pumps in the cells lining your stomach and shut them down. This dramatically lowers the total amount of acid in your stomach, which allows ulcers to heal and prevents acid from splashing into your esophagus.
The key distinction: PPIs change your stomach’s chemistry by suppressing acid production at the source. Carafate leaves acid production untouched and instead physically covers the vulnerable tissue so acid can’t reach it. Both can help ulcers heal, but they do so through fundamentally different pathways.
What Carafate Is Prescribed For
Carafate is FDA-approved as an antiulcer medication, primarily for duodenal ulcers (ulcers in the first part of the small intestine). It’s sometimes also used off-label for other conditions involving irritated or damaged tissue in the digestive tract, such as esophagitis from acid reflux. Because it works by direct contact with damaged tissue, you need to take it on an empty stomach, either one hour before eating or two hours after, so the medication can reach the ulcer site without being mixed into food.
Can You Take Carafate With a PPI?
Because Carafate and PPIs work through completely different mechanisms, they are sometimes used together. A PPI reduces the acid your stomach makes, while Carafate shields damaged tissue from whatever acid remains. This combination can be useful when one approach alone isn’t enough.
However, Carafate has an important quirk: it can physically bind to other medications in your digestive tract and prevent them from being absorbed. Studies have shown it reduces absorption of several common drugs, including certain antibiotics, seizure medications, thyroid hormone, and even some acid reducers. Taking other medications two hours before your Carafate dose typically eliminates this problem. Antacids should not be taken within 30 minutes of a Carafate dose.
Side Effects
Carafate is generally well tolerated. In studies of over 2,700 patients, only about 4.7% reported side effects. Constipation was the most common complaint, affecting about 2% of users. Less frequently reported effects include nausea, dry mouth, gas, dizziness, headache, and rash, each occurring in fewer than 0.5% of patients.
One specific concern applies to people with kidney problems. Carafate contains aluminum, and small amounts are absorbed during normal use. Healthy kidneys clear this aluminum without issue, but impaired kidneys cannot. Aluminum can accumulate over time in people with chronic kidney disease or those on dialysis, potentially leading to bone or neurological problems. Dialysis doesn’t help because the aluminum binds to blood proteins that are too large to pass through dialysis membranes. If you have kidney disease, this is worth discussing with your prescriber before starting Carafate.